Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
Johanna Nystedt, Director, Blood Products at Finnish Red Cross Blood Service, reposted from Veripalvelu – Finnish Red Cross Blood Service on LinkedIn:
”It is not every day we can release a new blood product to meet an unmet medical need – Today was one of those days!!
Quoting Veripalvelu – Finnish Red Cross Blood Service‘s post:
”The blood service will begin supplying serum eye drops to patients suffering from severe dry eye syndrome and surface eye diseases!
Serum eye drops are made from serum separated from donated blood.
Serum contains natural nutrients, vitamins, and growth factors that support the healing of the eye’s surface tissues and relieve inflammation.
The eye drops are intended for patients with severe dry eye syndrome, for example due to eye diseases, rheumatic diseases, or rejection following stem cell transplantation.
Blood for serum donation is currently collected at the Blood Service office in Seinäjoki.
“Donors feel that they play an important role in helping patients, and they have been happy to be able to help them in a new way,” says Anu Keisala, Head of Blood Donation Operations.”

Stay updated with Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action
